Our goal was to determine total and directly measured free 25-OH vitamin D serum levels in humans with a range of 25-OH vitamin D levels and clinical conditions associated with low and high vitamin D binding protein levels. Serum samples and clinical data were collected from 106 subjects: 62 without cirrhosis or pregnancy, 24 cirrhotic patients with albumin <2.9 g/dL, and 20 pregnant women.
INTRODUCTION
There continues to be debate about assessment of vitamin D status in humans based on circulating vitamin D or metabolite concentrations. There is agreement, however, that adequate status should be defined by concentrations of serum 25-OH vitamin D (D) (1) (2) (3) as this metabolite reflects overall body storage of the immediate vitamin D precursor that is hydroxylated to active 1,25-OH 2 vitamin D. Both circulating 1, 25-OH 2 D and 25-OH D bind to albumin and D binding protein leaving only a small fraction unbound or "free". Receptor and drug theory posit that only the "free" compound is available to bind to receptor. Or in the case of 25-OH D, only free is available for conversion to active 1, 25-OH 2 D and thus, may more closely reflect the biologic activity. The potential benefit of measuring "free or unbound" concentrations of D and its metabolites, especially in the presence of biologic conditions that alter levels of the carrier proteins, has been suggested. (4) (5) (6) (7) .
Until recently, determination of serum free 25-OH D was an arduous undertaking involving some form of equilibrium dialysis or indirect estimation based on measurement of D binding protein, albumin, and 25-OH D (using D standards and assays that were variable) with equations derived from relatively small numbers of people (4) or modified from equations used for sex hormones (8) . An assay that directly measures serum free 25-OH D levels has been developed (Future Diagnostics B.V., Wijchen, The Netherlands). The purpose of this investigation was to determine total and directly measured free 25-OH D in humans with a range of 25-OH D levels and clinical conditions associated with a range of D binding proteins levels. presented as mean ± S. D. and compared using ANOVA. Relationships between total and free 25-OH D concentrations were tested by linear regression and between group differences by ANOVA.
MATERIALS AND METHODS

Subjects
RESULTS.
One hundred and six subjects participated. Characteristics by group (cirrhotic, pregnant, and comparator) and mean values for total and free 25-OH D are presented in Table 1 . Cirrhotic patients had a mean Model for End-Stage Liver Disease MELD score of 16 ± 3 with Child Pugh score (9, 10) B in eight and C in twelve. Half of the pregnant women were in the second trimester of pregnancy and half were in the third. The comparator group had a mean Charlson co-morbidity score (11) of 3.7 ±3.4.
In the comparator group, five women were taking oral contraceptives and two received postmenopausal hormone replacement; no other sex hormones were taken. Total 25-OH D was significantly lower in cirrhotic patients with protein synthesis dysfunction but free 25-OH D concentrations were significantly higher in this group. Neither total nor free 25-OH D concentrations were significantly different in pregnant women compared to the comparator group. There were significant direct positive relationships between free 25-OH D and total 25-OH D concentrations for the entire dataset and for each group (p<.001), however the slopes of the relationships differed in the cirrhotic group compared to the pregnant women or the comparator group (free 25-OH D) y = 2.522 + .289 * X(total 25 OH-D), r 2 = .507, p<.001 cirrhotics; y = 1.451 + .094 * X; r 2 = .772, p<.0001 for pregnant women; and y = 1.112 + .122 * X; r 2 = .715, p<.0001 for the comparator group). Surprisingly not only was the ratio of free to total 25-OH D higher but the actual measured level of free 25-OH D was higher in patients with cirrhosis. Likewise surprising was that women in their second and third trimester of pregnancy did not have lower free total 25-OH vitamin D concentrations than the comparator group despite predicted increased DBP levels. However, these results are consistent with the observation made by Bikle et al. (15) that the affinity of DBP for the vitamin D metabolites appears to be decreased during pregnancy perhaps to compensate for the increased DBP concentrations without decreasing the free metabolite levels.
DISCUSSION
CONCLUSIONS.
Directly measured circulating free 25-OH vitamin D concentrations are a better means of assessing vitamin D sufficiency than total 25-OH D measurements in clinical conditions in which DBP and albumin levels are altered. Moreover, estimations of percent free 25-OH D levels based on DBP and albumin levels that assume a fixed affinity constant for the binding of 25 OH D to these proteins will be misleading in conditions in which this assumption is invalid. (7) Albumin ( Data are mean (S.D.) ** p<.001 for group differences for liver disease vs. other groups. ^ ns for differences between pregnant women and women in comparator group.# for conversion to S.I. units: albumin-multiple by 10 for g/L; calcium multiply by 0.25 for mmol/L; for 25-OH D multiply by 2.496 (for nmol/L or pmol/L) 
